What a High IgG Level Means and Its Common Causes

A high IgG level signals that your immune system is producing more of its most abundant antibody than expected, and the cause usually falls into one of a few broad categories: autoimmune disease, chronic infection, liver disease, or, less commonly, a blood-cell disorder. IgG makes up more than three-quarters of the immunoglobulins circulating in your blood, so when doctors see it elevated, the finding itself is nonspecific but the diagnostic trail it opens can be revealing. Whether the elevation is something to watch casually or investigate urgently depends on how high the number is, whether the extra IgG is one identical clone or a broad mix, and what other symptoms or lab results come along with it.

What IgG Actually Does

IgG is the workhorse antibody of adaptive immunity. It recognizes foreign invaders with one end and recruits immune cells or activates complement proteins with the other, essentially flagging threats and coordinating a response. Your body ramps up IgG production whenever it encounters something it considers dangerous, whether that is a virus, a bacterium, or, in autoimmune conditions, your own tissue.

Because IgG is produced in response to so many different triggers, a high level on a blood test is a starting point, not a diagnosis. Think of it like a fever: it tells you the body is reacting to something, but not what. The real question is always what is driving the elevation.

Polyclonal Versus Monoclonal Elevation

One of the first things a clinician determines after finding a high IgG is whether the elevation is polyclonal or monoclonal, because the two patterns point in very different directions.

A polyclonal rise means many different B cells are each making their own slightly different IgG molecules. On a lab test called serum protein electrophoresis, this shows up as a broad, diffuse band. Polyclonal elevations are the more common pattern and usually reflect a reactive process: chronic infection, autoimmune inflammation, or liver disease are the typical culprits. A retrospective study of 223 patients with marked polyclonal elevations (IgG above 15 g/L) found that autoimmune and connective-tissue diseases accounted for about a third of cases, chronic infections for roughly 28 percent, blood cancers for 14 percent, and liver disease for 9 percent.¹

A monoclonal spike, by contrast, means one single clone of B cells is churning out an identical antibody. This shows up as a sharp, narrow peak on electrophoresis. Monoclonal elevations raise concern for plasma-cell disorders, most notably a precursor state called monoclonal gammopathy of undetermined significance (MGUS), which carries a lifelong risk of progressing to multiple myeloma or a related malignancy.² Serum protein electrophoresis and immunofixation electrophoresis are the standard tests used to screen for and monitor these monoclonal conditions.³

Knowing whether the pattern is polyclonal or monoclonal reframes the entire workup. A polyclonal rise in someone with joint pain and a butterfly rash on the face points toward lupus. A monoclonal spike in an older adult with bone pain and anemia raises the question of myeloma. The IgG number alone cannot distinguish these scenarios.

Autoimmune Disease as the Leading Cause

Autoimmune conditions are the single most common driver of polyclonal IgG elevation. When the immune system misidentifies your own tissues as threats, it mounts a sustained antibody response that keeps IgG levels chronically elevated. Systemic lupus erythematosus (SLE) is probably the best-known example, but rheumatoid arthritis, Sjögren syndrome, and other connective-tissue disorders all fit the pattern.

In children, the connection is especially useful as a diagnostic clue. A pediatric study of children with elevated IgG found that close to half had underlying autoimmune conditions, with lupus and lupus-related disorders topping the list.⁴ So in a child with unexplained high IgG, an autoimmune workup is often the logical next step.

Chronic Infections

Infections that linger for weeks or months give the immune system persistent antigen exposure, and the B-cell system responds by pumping out IgG at elevated rates. HIV is the classic infectious cause in adults, but hepatitis B and C, tuberculosis, and chronic bacterial infections like endocarditis are also frequent contributors. In the large retrospective study mentioned above, chronic infections accounted for roughly 28 percent of marked polyclonal IgG elevations.¹

Parasitic infections deserve special mention. Animal research has shown that chronic parasitic infections produce extraordinarily high IgG levels, driven by persistent, high-dose stimulation of the B-cell system that depends on T-cell cooperation.⁵ Although this was demonstrated in mice, the general principle holds in humans: chronic parasitic disease, especially in tropical settings, is a well-recognized cause of high IgG.

Liver Disease

The liver plays a surprisingly important role in regulating immunoglobulin levels. It clears circulating immune complexes, and when it is damaged, that clearance slows down. At the same time, damaged liver tissue and increased gut permeability in cirrhosis expose the immune system to more bacterial products, stimulating additional IgG production.

IgG elevation is common across nearly all forms of cirrhosis, not just autoimmune hepatitis. A study comparing cirrhosis from different causes found elevated IgG in 47 to 97 percent of patients depending on the underlying etiology, with the highest IgG levels occurring in autoimmune hepatitis. At a cutoff of 2,000 mg/dL, the sensitivity for diagnosing autoimmune hepatitis in cirrhotic patients was about 82 percent and the specificity about 74 percent.⁶ In other words, a very high IgG in someone with cirrhosis makes autoimmune hepatitis more likely than, say, alcohol-related liver damage, but the overlap between causes is considerable.

IgG4-Related Disease

IgG4-related disease (IgG4-RD) is a relatively recently recognized condition that causes inflammatory masses and fibrosis in virtually any organ, from the pancreas to the salivary glands to the kidneys. It gets its name because affected tissues are packed with plasma cells that produce the IgG4 subclass, and many patients have elevated serum IgG4 levels.

The hallmark tissue findings are a dense lymphoplasmacytic infiltrate enriched with IgG4-positive plasma cells (with a ratio of IgG4 to total IgG plasma cells exceeding 40 percent), a distinctive swirling “storiform” pattern of fibrosis, and obliterative phlebitis, where inflammatory cells clog and destroy veins.⁷ One encouraging feature is that, unlike most fibrotic diseases, the scarring in IgG4-RD often responds to treatment and can partially reverse, particularly with B-cell depletion therapy.⁸

A practical point: mildly elevated serum IgG4 shows up in many conditions and is not, by itself, proof of IgG4-RD. Only markedly elevated levels (above 5 g/L) reach around 90 percent specificity for the diagnosis.⁹ Mild bumps in IgG4 can accompany ordinary allergic disease, autoimmune pancreatitis overlap, and other conditions, so tissue biopsy remains the gold standard for confirming IgG4-RD.

When High IgG Points Toward Blood Cancer

The monoclonal pattern described earlier warrants its own discussion because the stakes are higher. When a single clone of plasma cells grows unchecked, it secretes one identical IgG molecule in massive quantities, producing a monoclonal spike. The most common scenario is MGUS, a premalignant state that affects a small but meaningful percentage of adults over 50. MGUS itself does not cause symptoms, but it carries a lifelong risk of progressing to multiple myeloma or a related malignancy.²

Several factors help predict who with MGUS is most likely to progress. A high concentration of the monoclonal protein (the “M spike”) is one of the strongest risk factors: people with an M spike of 15 g/L or more had more than 23 times the odds of developing multiple myeloma compared with those who had lower concentrations. An abnormal ratio of free light chains in the blood was an even more dramatic predictor, with highly skewed ratios associated with more than 46 times the odds of progression.¹⁰ These numbers underscore why monitoring matters: the IgG level itself may not change dramatically from year to year, but shifts in the M spike concentration or light-chain ratio can signal that a previously stable condition is turning dangerous.

The Four IgG Subclasses

IgG is not a single uniform molecule. It comes in four subclasses, labeled IgG1 through IgG4, and they differ in how they interact with other parts of the immune system. The subclasses have different hinges and upper regions in their structure, which translates into different abilities to trigger immune-cell activation, promote phagocytosis, or activate complement.¹¹

For most people, a routine blood test measures total IgG without breaking it into subclasses. Subclass testing becomes relevant in specific situations: when IgG4-related disease is suspected, when a selective subclass deficiency (especially IgG2 or IgG4) is being investigated in someone with recurrent infections, or when the total IgG is elevated and the clinician wants to know which subclass is responsible. Measuring IgG subclasses alongside C-reactive protein can help narrow the differential in polyclonal elevations.⁹

Lifestyle Factors That Can Raise IgG

Chronic alcohol use and excess body fat both promote low-grade inflammation, and that inflammation can nudge IgG levels upward. When alcohol is metabolized, it produces toxic byproducts and reactive oxygen species that activate inflammatory pathways. Heavy drinking also damages the gut lining, allowing bacterial products to leak into the bloodstream and further stoke the immune response. Fat tissue, meanwhile, harbors immune cells that secrete inflammatory signals of their own. Research has found that genetic susceptibility to inflammation, combined with higher alcohol intake and greater body fat, can synergistically raise IgG levels, while maintaining a healthy weight and avoiding alcohol may counteract that genetic predisposition.¹²

This does not mean every person who drinks or carries extra weight will have a noticeably high IgG. The effect is typically modest compared with the elevations caused by autoimmune disease or myeloma. But if you have a mildly elevated IgG and no clear medical explanation, these lifestyle factors are worth considering, especially if other inflammatory markers are also slightly up.

When Treatment Itself Is the Cause

Intravenous immunoglobulin (IVIg) therapy deliberately floods the bloodstream with pooled IgG from donors. It is used to treat a range of neurological and autoimmune conditions, including Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP). In Guillain-Barré patients, a larger rise in serum IgG after a standard IVIg infusion has been associated with better outcomes, suggesting that the body’s handling of the infused immunoglobulin varies widely between individuals.¹³

A practical complication of IVIg is that serum IgG levels can swing dramatically between infusions. In one case, a CIDP patient receiving intravenous immunoglobulin experienced severe symptom fluctuations linked to volatile IgG levels; switching to subcutaneous immunoglobulin stabilized both the IgG concentration and the patient’s symptoms.¹⁴ If you are receiving immunoglobulin therapy and see a high IgG on bloodwork, the infusion itself is the most likely explanation, and the level may not reflect your underlying immune status at all.

Rare Conditions Worth Knowing About

A handful of uncommon diseases can produce strikingly high IgG that does not fit the usual categories. Autoimmune lymphoproliferative syndrome (ALPS) is an inherited disorder in which a defect in the normal cell-death pathway allows autoreactive immune cells to accumulate. This leads to enlarged lymph nodes, an enlarged spleen, autoimmune blood-cell destruction, and elevated immunoglobulins, along with a significantly increased lifetime risk of lymphoma.¹⁵ ALPS is usually diagnosed in childhood and can mimic other immune disorders, making the expanded IgG level just one piece of a larger puzzle.

Castleman disease and certain histiocyte disorders also appear on the differential for polyclonal IgG elevation. These are rare enough that most clinicians will not encounter them frequently, but they are important to exclude when the usual workup for infection, autoimmune disease, and liver disease comes up empty.⁹ IL-6-driven inflammation, which can be measured indirectly through a persistently elevated C-reactive protein (above 30 mg/L), is a recognized driver of polyclonal elevation in some of these cases.

When the Lab Result Itself Is Wrong

Before chasing a disease, it is worth remembering that immunoassays are not infallible. Substances in the blood can interfere with the antibody-based reactions that these tests rely on. Natural polyreactive antibodies, human anti-animal antibodies (common in people who have received certain diagnostic or therapeutic agents), and even lipemia from a recent fatty meal can all produce falsely elevated or falsely low results.¹⁶

If a high IgG result does not match the clinical picture at all, your doctor may repeat the test using a different assay method, check for known interfering substances, or look at related markers to see whether the elevation is consistent. A single mildly elevated IgG in an otherwise healthy person is rarely an emergency, but it should be repeated and, if confirmed, investigated in context.

Hyperviscosity and When High IgG Becomes Dangerous on Its Own

In most cases, the high IgG level is a symptom, not the problem. But at extreme concentrations, immunoglobulins can physically thicken the blood to the point where it flows poorly through small vessels, a condition called hyperviscosity syndrome. This is a rare complication of both monoclonal and polyclonal elevations and can cause blurred vision, headaches, mucosal bleeding, and neurological symptoms like confusion or dizziness.¹⁷

Hyperviscosity is most closely associated with Waldenström macroglobulinemia (which involves IgM rather than IgG) and with very advanced myeloma. Polyclonal elevations rarely reach the concentrations needed to cause it, though it has been reported. Treatment involves plasmapheresis to rapidly remove excess immunoglobulin from the blood, followed by addressing whatever is driving the overproduction. If you have an extremely high IgG and develop new visual changes, unexplained bleeding, or neurological symptoms, those warrant urgent medical attention.